Concerning the expression level of RUFY3 and clinical characteristics of lung cancer, we discovered that higher expression of RUFY3 may also be associated with lymph node metastasis and TNM staging. The gene discussed is RUFY3; the disease is metastatic malignant neoplasm in the lymph nodes.